Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias

por Kaye, James A., Margulis, Andrea V., Fortuny, Joan, McQuay, Lisa J., Plana, Estel, Bartsch, Jennifer L., Bui, Christine L., Perez‐Gutthann, Susana, Arana, Alejandro
Publicado en Pharmacotherapy (2017)

Validation of cardiovascular outcomes and risk factors in the Clinical Practice Research Datalink in the United Kingdom

por Arana, Alejandro, Margulis, Andrea V, Varas‐Lorenzo, Cristina, Bui, Christine L, Gilsenan, Alicia, McQuay, Lisa J, Reynolds, Maria, Rebordosa, Cristina, Franks, Billy, de Vogel, Stefan, Appenteng, Kwame, Perez‐Gutthann, Susana
Publicado en Pharmacoepidemiol Drug Saf (2020)

Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom

por Margulis, Andrea V., Linder, Marie, Arana, Alejandro, Pottegård, Anton, Berglind, Ina Anveden, Bui, Christine L., Kristiansen, Nina Sahlertz, Bahmanyar, Shahram, McQuay, Lisa J., Atsma, Willem Jan, Appenteng, Kwame, D'Silva, Milbhor, Perez-Gutthann, Susana, Hallas, Jesper
Publicado en PLoS One (2018)

Risk of Acute Liver Injury Associated with the Use of Moxifloxacin and Other Oral Antimicrobials: A Retrospective, Population-Based Cohort Study

por Kaye, James A, Castellsague, Jordi, Bui, Christine L, Calingaert, Brian, McQuay, Lisa J, Riera-Guardia, Nuria, Saltus, Catherine W, Quinlan, Scott, Holick, Crystal N, Wahl, Peter M, Suzart, Kiliana, Rothman, Kenneth J, Wallander, Mari-Ann, Perez-Gutthann, Susana
Publicado en Pharmacotherapy (2014)